BridgeView Life Sciences
BridgeView Life Sciences provides SaaS platforms and consulting services to pharmaceutical, biotechnology, and medical device firms, specializing in commercial data management, CRM implementation, AI-enabled content review, and program management across the Veeva and Salesforce technology stacks.
- Company typePrivate
- Founded2021
- HeadquartersPaoli, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What BridgeView Life Sciences does
BridgeView Life Sciences LLC provides SaaS platforms and consulting services to pharmaceutical, biotechnology, and medical device organizations, operating as a wholly-owned subsidiary of Zensar Technologies (an RPG Group company) since August 2024. The company traces its origin to COEUS Solutions, launched in March 2021 and rebranded as BridgeView Life Sciences in April 2024 following a spinoff from predecessor COEUS Holdings; predecessor entity Afore, LLC was acquired in September 2021 to expand technology capabilities. The product portfolio centers on three core cloud-native SaaS platforms — DataBridge (commercial data warehouse), PatientBridge (specialty patient data aggregation with HIPAA-compliant dashboards), and CommandBridge (program management for large initiatives) — augmented by the 2026 ZenseAI.Veeva suite covering GenAI-powered Field Enablement on Veeva DAM, an AI-driven AMS agent for Veeva Vault support, and a Key Account Management Accelerator integrated with Veeva Vault CRM. Strategic partnerships with Vodori (2026, MLR content review), Veeva (Global Service Partner since 2018), Salesforce (Platinum, including Life Science Cloud), Snowflake, Reltio, Databricks, IQVIA, Aprimo, and others enable integrated solutions across the life sciences technology stack.
Revenue is generated through three streams: subscription/recurring SaaS platforms (DataBridge, PatientBridge, CommandBridge), professional services consulting (Strategy Consulting, Business Transformation, CRM and Business Applications, Information Management and Analytics, Quality Assurance, Technology Training, Managed Services, PMO), and managed services/staff augmentation across US onshore and LATAM/Canada nearshore delivery. Customers span large global pharma, mid-size pharma, biotech (including ultra-rare and oncology), and MedTech organizations; sales are executed via enterprise field sales targeting CXO/VP stakeholders with documented $3M+ annual total contract value deals, supplemented by partner-channel referrals from technology vendors and conference-driven pipeline development. Quantified outcomes cited by the company include 30-60% faster MLR review cycles, 40% acceleration in content approvals (Abiomed case study), up to 30% reduction in operational costs via Agentic AI support, and 30-40% effort savings with automated access management, with compliance maintained across 21 CFR Part 11, EU Annex 11, GxP, HIPAA, and FDA frameworks.
BridgeView Life Sciences firmographics
Firmographics- Name
- BridgeView Life Sciences
- Legal name
- BridgeView Life Sciences LLC
- Website
- https://bridgeviewls.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- BridgeView Life Sciences provides SaaS platforms and consulting services to pharmaceutical, biotechnology, and medical device firms, specializing in commercial data management, CRM implementation, AI-enabled content review, and program management across the Veeva and Salesforce technology stacks.
- Ownership category
- akta.pro rank
BridgeView Life Sciences industry classification
Industry- Product category
- Life Sciences Consulting and SaaS
- NAICS
- Management Consulting Services (54161), Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
- SIC
- Services-Management Consulting Services (8742), Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
- akta.pro primary industry
- Data, Analytics & AI Consulting (BPAHAEAF)
- akta.pro secondary industries
- Software/Application Support (SaaS, Enterprise Apps) (BPAAACAC), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
Keywords
Where BridgeView Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Paoli
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BridgeView Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Products: Cloud-native SaaS platforms including DataBridge, PatientBridge, and CommandBridge for commercial data management, patient data aggregation, and program management. Revenue generated through platform subscriptions and usage.
- Consulting Services: Comprehensive range of strategies, solutions, insights, and managed services including Strategy Consulting, Business Transformation, Program Management Office, CRM & Business Applications, Information Management & Analytics, Quality Assurance, Technology Training, and Staff Augmentation. Revenue generated through professional services engagements.
- Managed Services: Ongoing support services for operation and optimization including world-class system administration, data management, and staff augmentation. Delivered through dedicated managed teams with predictable recurring revenue.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
BridgeView Life Sciences product offering
Product offeringCore offering
BridgeView Life Sciences sells cloud-native SaaS platforms (DataBridge, PatientBridge, CommandBridge) and AI-enabled Veeva modules (ZenseAI.Veeva.Field Enablement, ZenseAI.Veeva.AMS, Vault CRM KAM Accelerator) to pharmaceutical, biotech, and medtech organizations for commercial data management, patient journey analytics, program management, and compliant content review. The company complements these products with a full suite of consulting services including strategy, business transformation, CRM implementation, information management, quality assurance, managed services, and staff augmentation.
Product overview
BridgeView Life Sciences offers a portfolio of three core SaaS products (DataBridge, PatientBridge, CommandBridge) supported by ZenseAI.Veeva specialized modules (Field Enablement, AMS, KAM Accelerator) and strategic partnerships. DataBridge serves as the commercial data warehouse platform for data synthesis and analytics; PatientBridge handles specialty patient data aggregation with HIPAA-compliant dashboards; CommandBridge provides program management for large-scale initiatives. ZenseAI.Veeva modules add AI-powered capabilities for Veeva CRM environments, including field enablement with GenAI, AI-driven application support, and key account management. The MLR partnership with Vodori extends capabilities for compliant content review with 30-60% faster cycles. Comprehensive consulting services span strategy, business transformation, CRM, information management, quality assurance, training, managed services, and staff augmentation.
Differentiator
Problem solved
Functional benefit
Brands
- DataBridge: Commercial data warehouse platform providing flexible, scalable data synthesis, enrichment, and application for commercial stakeholders.
- PatientBridge
- CommandBridge
Products and services
- DataBridge Cloud-native commercial data warehouse platform that ingests, stores, governs, and analyzes data from heterogeneous sources including databases, business applications, and industry-standard solutions. Enables accurate ad-hoc analysis, rapid BI reporting, and AI/ML-enabled advanced data science for commercial stakeholders at pharmaceutical and biotech organizations.
- PatientBridge Specialty data aggregation platform providing near real-time insights beyond traditional channel and prescriber commercial metrics. Validates, tokenizes, masters, and harmonizes data from multiple sources across the product and patient journey, visualizing HIPAA-compliant data in dashboards for trade, market access, and sales teams.
- CommandBridge Program management SaaS platform that strengthens role-specific decision making for large-scale initiatives and operations. Automates subjective topics, bridges information gaps to accelerate planning and launches, mitigates risk, ensures compliance and audit readiness, and creates a single source of truth for program stakeholders.
- ZenseAI.Veeva.Field Enablement
Quantifiable outcome
- 30-60% faster MLR review cycles while maintaining compliance
- +4 more outcomes
Companies that use BridgeView Life Sciences
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles3 records
BridgeView Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration15 records
AI capability13 records
Feature8 records
BridgeView Life Sciences partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, major, standard, notable and minor.
- VodoricoreStrategic partnership announced January 2026 combining Vodori's MLR content review technology with BridgeView's regulatory expertise and implementation support. Joint solution enables 30-60% faster review cycles while maintaining 21 CFR Part 11 and EU Annex 11 compliance. Both companies are Salesforce Life Science Cloud partners. Fixed-price implementation bundle enables go-live in 4-8 weeks.
- Veeva SystemscoreGlobal Service Partner to Veeva Systems since 2018. BridgeView delivers end-to-end Veeva Vault services including configuration, compliance, PromoMats, MedComms, Training, RIM, and CRM implementations. Certified experts help streamline processes and ensure regulatory readiness.
- SalesforcecoreSalesforce Platinum Partner with expertise in Salesforce Health Cloud, Sales Cloud, Service Cloud, and Marketing Cloud implementations. Both BridgeView and Vodori are Salesforce Life Science Cloud partners, enabling integrated solutions.
- SnowflakemajorSnowflake partner providing cloud data platform expertise. BridgeView offers Snowflake Solution Architect roles and Snowflake-based data platform implementations for life sciences customers.
- ReltiomajorReltio partner offering AI-powered data unification and Master Data Management (MDM) solutions. Reltio's multidomain MDM platform integrates with BridgeView's data management services.
- IQVIAmajorPartnership with IQVIA for advanced analytics, technology solutions, and clinical research services. IQVIA provides analytics, transformative technology, big data resources, and domain expertise across healthcare.
- DatabricksmajorDatabricks partner providing unified Data and AI platform for life sciences organizations. BridgeView leverages Databricks for consolidating data, building AI-driven applications, and ensuring secure governance.
- AprimostandardAprimo partner offering Digital Asset Management, Work Management, and Marketing Budget Management solutions. Integration supports content operations and MLR review workflows.
- IntegriChainnotableIntegriChain acquired BridgeView Data Solutions in 2024, creating best-in-class commercial data solution for pharma. Partnership focuses on data, technology, consulting, and outsourcing connecting commercial, financial, and operational dimensions of drug access.
- MedPro SystemsstandardMedPro partner providing aggregate spend, DSCSA, PDMA, and Stark Law compliance solutions through MedProID platform and expert compliance advisory services.
- SmartsheetstandardSmartsheet partner providing enterprise platform for modern work management. BridgeView utilizes Smartsheet for project management and program tracking.
- ImmPACT BiominorImmPACT Bio develops logic-gate-based CAR T platforms addressing key challenges for cell therapies in oncology. Partnership supports biotech innovation in cell therapy space.
- Zensar TechnologiescoreBridgeView Life Sciences was acquired by Zensar Technologies, a leading experience, engineering, and technology solutions company. Zensar provides global scale and digital expertise enabling BridgeView to reach wider audience. BridgeView's transformation expertise enhances Zensar's life sciences offerings.
Scale indicators4 records
Recent moves8 records
Expansion highlights6 records
BridgeView Life Sciences competitors and assessment
Company assessmentDirect peers
- ZS Associates: Premier global life sciences consulting firm with deep commercial, data, and analytics practices serving top pharma and biotech. Competes directly with BridgeView on CRM, data management, and sales force optimization engagements for the same enterprise buyers.
- IQVIA: Largest life sciences technology and analytics provider; overlaps with BridgeView in commercial data, technology services, and analytics — and is also a named BridgeView partner, reflecting the dual competitor-and-partner dynamic in this space.
- Axtria: Life sciences-focused data analytics and commercial operations consultancy. Competes head-to-head with BridgeView on sales/marketing analytics, data management, and CRM implementations for pharma and biotech clients.
- Indegene: Life sciences digital services and commercial outsourcing company serving global pharma and biotech. Directly comparable to BridgeView's commercial launch, MLR, and digital content capabilities.
- Navience Life Sciences: Life sciences commercial consulting and data analytics firm focused on pricing, market access, and customer engagement. Overlaps with BridgeView's PatientBridge and commercial data practices for mid-market pharma.
Broad incumbents
- Accenture Life Sciences: Global IT services practice serving top pharma and medtech accounts. Competes with BridgeView on large CRM, data, and digital transformation engagements as a much larger incumbent with broader capabilities.
- Cognizant Life Sciences: Global IT services and consulting firm with a sizable life sciences practice providing CRM, data, and digital transformation services. Competes with BridgeView on enterprise pharma IT services and Veeva implementations.
- Deloitte Life Sciences Consulting: Big Four advisory practice with a global life sciences consulting business. Competes with BridgeView on enterprise strategy, transformation, and compliance-related advisory for pharma and medtech clients.
- Wipro Life Sciences: Global IT services firm with a dedicated life sciences digital practice serving pharma, biotech, and medtech with CRM, data, and engineering services. Analogous incumbent to BridgeView's niche offering at much larger scale.
- Capgemini Engineering: Global digital engineering and consulting firm with life sciences capabilities across data, cloud, and digital transformation. Competes with BridgeView for large enterprise pharma programs where global delivery scale is required.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
BridgeView Life Sciences social profiles
Digital presenceBridgeView Life Sciences compliance and trust
Trust signalCompliance5 records
BridgeView Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
BridgeView Life Sciences leadership team
Management profileNumber of profiles
Profiles4 records
BridgeView Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BridgeView Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BridgeView Life Sciences
What does BridgeView Life Sciences do?
BridgeView Life Sciences sells cloud-native SaaS platforms (DataBridge, PatientBridge, CommandBridge) and AI-enabled Veeva modules (ZenseAI.Veeva.Field Enablement, ZenseAI.Veeva.AMS, Vault CRM KAM Accelerator) to pharmaceutical, biotech, and medtech organizations for commercial data management, patient journey analytics, program management, and compliant content review. The company complements these products with a full suite of consulting services including strategy, business transformation, CRM implementation, information management, quality assurance, managed services, and staff augmentation.
Is BridgeView Life Sciences a public or private company?
BridgeView Life Sciences is a private company. It is classified as corporate owned and is currently operating.
When was BridgeView Life Sciences founded?
BridgeView Life Sciences was founded in 2021. It employs 51 to 100 people.
Where is BridgeView Life Sciences based?
BridgeView Life Sciences is headquartered in Paoli, United States, in the North America region.
How does BridgeView Life Sciences make money?
Three revenue lines are on record. SaaS Products are the primary driver. The others are consulting Services and managed Services.
Who are BridgeView Life Sciences's main competitors?
Direct peers on record are ZS Associates, IQVIA, Axtria, Indegene and Navience Life Sciences. Broad incumbents are Accenture Life Sciences, Cognizant Life Sciences, Deloitte Life Sciences Consulting, Wipro Life Sciences and Capgemini Engineering.
Does BridgeView Life Sciences have an API?
No public API is recorded for BridgeView Life Sciences.
What industry is BridgeView Life Sciences in?
BridgeView Life Sciences's product category is Life Sciences Consulting and SaaS. Its primary akta.pro industry code is BPAHAEAF, Data, Analytics & AI Consulting, with a secondary code of BPAAACAC, Software/Application Support (SaaS, Enterprise Apps). Its NAICS code is 54161 and its SIC code is 8742.